http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103833540-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C225-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-835 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-835 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C221-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C225-16 |
| filingDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103833540-B |
| titleOfInvention | A kind of beta substitution cinnamophenone analogue and its preparation method and the application in preparation NSC 630176 |
| abstract | The present invention discloses a kind of beta substitution cinnamophenone analogue and its preparation method and the application in preparation NSC 630176. Does the present invention utilize the method for two step fluorometric investigations to formula? I? a compounds carried out the active testing of histon deacetylase (HDAC), it was demonstrated that histon deacetylase (HDAC) is had optionally restraining effect by it, is expected to for the treatment to tumor disease. |
| priorityDate | 2013-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.